Effects of valbenazine in Huntington’s disease as measured by wearable movement sensors: A substudy of the phase 3 KINECT®-HD trial

Parkinsonism & Related Disorders · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles